BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 22984226)

  • 1. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation.
    Kim K; Bae ON; Lim KM; Noh JY; Kang S; Chung KY; Chung JH
    J Pharmacol Exp Ther; 2012 Dec; 343(3):704-11. PubMed ID: 22984226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Effects of Paeoniflorin from
    Ngo T; Kim K; Bian Y; Noh H; Lim KM; Chung JH; Bae ON
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
    J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effect of SP-8008, a benzoic acid derivative, through the selective inhibition of shear stress-induced platelet aggregation.
    Ngo T; Kim K; Bian Y; Nam G; Park HJ; Lee K; Cho GS; Ryu JM; Lim KM; Chung JH
    Br J Pharmacol; 2020 Feb; 177(4):929-944. PubMed ID: 31648364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High shear stress induced platelet aggregation (h-SIPA) and effects of antiplatelet therapy].
    Isaka N; Tanigawa T; Nishikawa M; Nakano T
    Nihon Rinsho; 1998 Oct; 56(10):2624-9. PubMed ID: 9796329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
    Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
    Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
    Priya N; Singh P; Bhatia S; Medhi B; Prasad AK; Parmar VS; Raj HG
    J Pharm Pharmacol; 2011 Sep; 63(9):1175-85. PubMed ID: 21827490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
    Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
    Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
    J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
    Bae ON
    Arch Pharm Res; 2012 Oct; 35(10):1693-9. PubMed ID: 23139119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
    Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
    Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.